研究单位：[1]Dongzhimen Hospital, Beijing[2]China-Japan Friendship Hospital,Beijing,Beijing,China[3]Dongzhimen Hospital Beijing University of Chinese Medicine,Beijing,Beijing,China[4]The First Affiliated Hospital of Chongqing Medical University,Chongqing,Chongqing,China[5]Guangdong Provincial Hospital of Chinese Medicine,Guangzhou,Guangdong,China[6]The First Hospital of Hebei Medical University,Shijiazhuang,Hebei,China[7]The First Affiliated Hospital of Henan University of CM,Zhengzhou,Henan,China
This study adopted a randomized, double-blind, placebo-controlled, multicenter clinical design and compared the effects of Yangxinshi tablet and placebo on exercise tolerance in patients with chronic coronary syndrome (CCS).
